World's Best Scientists 2026 revealed!
Sun Young Rha

Sun Young Rha

D-Index & Metrics

Medicine

D-Index
89
Citations
33495
World Ranking
12572
National Ranking
37

Overview

Sun Young Rha is affiliated with Yonsei University in South Korea and specializes in the field of Medicine, with significant contributions spanning several subfields including Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology, and Gastroenterology.

Their research work covers various key topics such as:

  • Gastric Cancer Management and Outcomes
  • Cancer Immunotherapy and Biomarkers
  • Gastrointestinal Tumor Research and Treatment
  • Colorectal Cancer Treatments and Studies
  • Esophageal Cancer Research and Treatment
  • Renal cell carcinoma treatment
  • HER2/EGFR in Cancer Research

Sun Young Rha has published extensively in notable scientific journals. Frequent publication venues include:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • Cancer Research
  • ESMO Open
  • Cancer Research and Treatment

Noteworthy recent papers authored or co-authored by Sun Young Rha are:

  • Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial, 2023, The Lancet Oncology
  • Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma, 2021, New England Journal of Medicine (lead author Robert J. Motzer)
  • Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer, 2022, New England Journal of Medicine (lead author John H. Strickler)
  • Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial, 2023, The Lancet (lead author Yelena Y. Janjigian)
  • PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer, 2021, Journal of Clinical Oncology (lead author Yoon-Koo Kang)

Their collaborative network includes frequent co-authors such as:

  • Hyun Cheol Chung (71 publications)
  • Do-Youn Oh (55 publications)
  • Woo Sun Kwon (49 publications)
  • Minkyu Jung (42 publications)
  • Hyo Song Kim (41 publications)

Best Publications

  • Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

    Atsushi Ohtsu;Manish A. Shah;Eric Van Cutsem;Sun Young Rha

  • Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

    Robert Motzer;Boris Alekseev;Sun Young Rha;Camillo Porta

  • External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study

    Daniel Y.C. Heng;Wanling Xie;Meredith M. Regan;Lauren C. Harshman

  • Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial

    Patrick Schöffski;Sant Chawla;Robert G. Maki;Antoine Italiano

  • A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets

    Niantao Deng;Liang Kee Goh;Hannah Wang;Kakoli Das

  • Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes

    Zhi Jiang Zang;Ioana Cutcutache;Song Ling Poon;Shen Li Zhang

  • Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer

    Keun Seok Lee;Hyun Cheol Chung;Seock Ah Im;Yeon Hee Park

  • Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Renal Cell Carcinoma

    Robert J. Motzer;Carlos H. Barrios;Tae Min Kim;Silvia Falcon

  • Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

    Daniel Y.C. Heng;J. Connor Wells;Brian I. Rini;Benoit Beuselinck

  • Oncogenic Pathway Combinations Predict Clinical Prognosis in Gastric Cancer

    Chia Huey Ooi;Tatiana Ivanova;Jeanie Wu;Minghui Lee

  • The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study

    Jenny J. Ko;Wanling Xie;Nils Kroeger;Jae lyun Lee

  • Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy

    Iain Beehuat Tan;Tatiana Ivanova;Kiat Hon Lim;Chee Wee Ong

  • Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial

    Yung Jue Bang;Rui Hua Xu;Keisho Chin;Keun Wook Lee

  • Whole genome analysis for liver metastasis gene signatures in colorectal cancer.

    Dong Hyuk Ki;Hei-Cheul Jeung;Chan Hee Park;Seung Hee Kang

  • Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial

    Robert John Motzer;Camillo Porta;Nicholas J Vogelzang;Cora N Sternberg

  • Metastatic non–clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consortium criteria

    Nils Kroeger;Wanling Xie;Jae Lyn Lee;Georg A. Bjarnason

  • Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy.

    Rana R. McKay;Nils Kroeger;Nils Kroeger;Wanling Xie;Jae Lyun Lee

  • Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases

    S. H. Cheon;S. Y. Rha;H. C. Jeung;C. K. Im

  • Epigenetic Therapy Using Belinostat for Patients With Unresectable Hepatocellular Carcinoma: A Multicenter Phase I/II Study With Biomarker and Pharmacokinetic Analysis of Tumors From Patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group

    Winnie Yeo;Hyun C. Chung;Stephen L. Chan;Ling Z. Wang

  • Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas

    Suling J. Lin;Johann A Gagnon-Bartsch;Iain Beehuat Tan;Sophie Earle

Frequent Co-Authors

Hyun Cheol Chung
Hyun Cheol Chung Yonsei University
Sung Hoon Noh
Sung Hoon Noh Yonsei University
Toni K. Choueiri
Toni K. Choueiri Harvard University
Woo Jin Hyung
Woo Jin Hyung Yonsei University
Brian I. Rini
Brian I. Rini Vanderbilt University Medical Center
Patrick Tan
Patrick Tan Duke NUS Graduate Medical School
Ulka N. Vaishampayan
Ulka N. Vaishampayan University of Michigan–Ann Arbor
Georg A. Bjarnason
Georg A. Bjarnason Sunnybrook Health Science Centre
Yoon-Koo Kang
Yoon-Koo Kang Asan Medical Center
Christian Kollmannsberger
Christian Kollmannsberger University of British Columbia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The journey to a career in medicine offers several diverse paths, many of which can be accessed or advanced through online programs. Besides the traditional MD, students and working professionals often consider flexible online healthcare degrees to expand their qualifications and career options.

Mental health is an area in high demand. For nurses aiming to specialize further, there are shortest post master's pmhnp online programs available, allowing experienced nurses to quickly become Psychiatric Mental Health Nurse Practitioners.

If your interest leans toward the business or administrative side of healthcare, an accredited health care administration degree online can lead to management opportunities in hospitals, government, or private practice. Many prospective leaders also seek accredited graduate programs, such as the cheapest mha programs online, to gain deeper expertise in managing healthcare organizations.

For those looking to reach the highest levels of clinical practice and leadership, there are also most affordable online dnp programs that allow nurses to achieve a Doctor of Nursing Practice remotely—and often at a lower cost.

Exploring these related online degrees offers more flexibility and new career pathways for those passionate about making a difference in medicine and healthcare.

Best Scientists Citing Sun Young Rha

Trending Scientists